Early-stage amyloid transthyretin cardiomyopathy: uncertainties and opportunities
Eur Heart J
.
2022 Jul 14;43(27):2633-2635.
doi: 10.1093/eurheartj/ehac261.
Authors
Claudio Rapezzi
1
2
,
Matteo Serenelli
1
,
Alberto Aimo
3
4
Affiliations
1
Cardiologic Centre, University of Ferrara, Ospedale di Cona, Via Aldo Moro 8, 44124 Cona (Ferrara), Italy.
2
Maria Cecilia Hospital, GVM Care & Research, Cotignola (Ravenna), Italy.
3
Institute of Life Sciences, Scuola Superiore Sant'Anna, Pisa, Italy.
4
Cardiology Division, Fondazione Toscana Gabriele Monasterio, Pisa, Italy.
PMID:
35639645
DOI:
10.1093/eurheartj/ehac261
No abstract available
Publication types
Editorial
Comment
MeSH terms
Amyloid Neuropathies, Familial* / complications
Cardiomyopathies*
Humans
Prealbumin / genetics
Substances
Prealbumin
Supplementary concepts
Amyloidosis, Hereditary, Transthyretin-Related